| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Mytrang H Do, Wei Shi, Liangliang Ji, Erik Ladewig, Xian Zhang, Raghvendra M Srivastava, Kristelle J Capistrano, Chaucie Edwards, Isha Malik, Briana G Nixon, Efstathios G Stamatiades, Ming Liu, Shun Li, Peng Li, Chun Chou, Ke Xu, Ting-Wei Hsu, Xinxin Wang, Timothy A Chan, Christina S Leslie, Ming O L. Reprogramming tumor-associated macrophages to outcompete endovascular endothelial progenitor cells and suppress tumor neoangiogenesis. Immunity. vol 56. issue 11. 2023-11-15. PMID:37967531. |
tams had low activity of the metabolic regulator mammalian/mechanistic target of rapamycin complex 1 (mtorc1), and depletion of negative regulator of mtorc1 signaling, tuberous sclerosis complex 1 (tsc1), in tams inhibited tumor growth in a manner independent of adaptive lymphocytes. |
2023-11-15 |
2023-11-20 |
Not clear |
| D Mammadova, J Vecko, M Hofmann, S C Sch\\xc3\\xbcssler, L Deiters, A Canda, A K Wieland, S Gollwitzer, H Hamer, Regina Trollman. A single-center observational study on long-term neurodevelopmental outcomes in children with tuberous sclerosis complex. Orphanet journal of rare diseases. vol 18. issue 1. 2023-11-10. PMID:37946245. |
tuberous sclerosis complex (tsc) is a rare multisystem disorder caused by mutations in the tsc1 or tsc2 gene. |
2023-11-10 |
2023-11-20 |
Not clear |
| Inci S Aksoylu, Pauline Martin, Francis Robert, Krzysztof J Szkop, Nicholas E Redmond, Srirupa Bhattacharyya, Jennifer Wang, Shan Chen, Roberta L Beauchamp, Irene Nobeli, Jerry Pelletier, Ola Larsson, Vijaya Rames. Translatome analysis of tuberous sclerosis complex 1 patient-derived neural progenitor cells reveals rapamycin-dependent and independent alterations. Molecular autism. vol 14. issue 1. 2023-10-26. PMID:37880800. |
tuberous sclerosis complex (tsc) is an inherited neurocutaneous disorder caused by mutations in the tsc1 or tsc2 genes, with patients often exhibiting neurodevelopmental (nd) manifestations termed tsc-associated neuropsychiatric disorders (tand) including autism spectrum disorder (asd) and intellectual disability. |
2023-10-26 |
2023-11-08 |
Not clear |
| Paolo Curatolo, Mirte Scheper, Leonardo Emberti Gialloreti, Nicola Specchio, Eleonora Aronic. Is tuberous sclerosis complex-associated autism a preventable and treatable disorder? World journal of pediatrics : WJP. 2023-10-25. PMID:37878130. |
tuberous sclerosis complex (tsc) is a genetic disorder caused by inactivating mutations in the tsc1 and tsc2 genes, causing overactivation of the mechanistic (previously referred to as mammalian) target of rapamycin (mtor) signaling pathway in fetal life. |
2023-10-25 |
2023-11-08 |
Not clear |
| Ashwini Sri Hari, Rajeswari Banerji, Li-Ping Liang, Ruth E Fulton, Christopher Quoc Huynh, Timothy Fabisiak, Pallavi Bhuyan McElroy, James R Roede, Manisha Pate. Increasing glutathione levels by a novel posttranslational mechanism inhibits neuronal hyperexcitability. Redox biology. vol 67. 2023-10-01. PMID:37769522. |
furthermore, bso-mediated gsh depletion oxidatively modified the tuberous sclerosis protein complex (tsc) consisting of hamartin (tsc1), tuberin (tsc2), and tbc1 domain family member 7 (tbc1d7) which are critical negative regulators of mtorc1. |
2023-10-01 |
2023-10-07 |
zebrafish |
| Gurneel K Dhanesar, Harish Rengarajan, Baidarbhi Chakrabort. Malignant Perivascular Epithelioid Cell Tumor of the Uterus. Cureus. vol 15. issue 7. 2023-08-14. PMID:37575749. |
they belong to the family of mesenchymal tumors and include angiomyolipomas, clear cell sugar tumors of the lung, and pecomas not otherwise specified (nos).\xc2\xa0tuberous sclerosis complex 1 (tsc1) and tuberous sclerosis complex 2 (tsc2) gene mutation is associated with pecoma, which causes hyperactivation of the mammalian target of rapamycin (mtor) signaling pathway. |
2023-08-14 |
2023-08-16 |
Not clear |
| Sameer C Dhamne, Meera E Modi, Audrey Gray, Simone Bonazzi, Lucas Craig, Elizabeth Bainbridge, Lahin Lalani, Chloe E Super, Samantha Schaeffer, Ketthsy Capre, Danuta Lubicka, Guiqing Liang, Doug Burdette, Stephanie M McTighe, Sarika Gurnani, Sheryl Anne D Vermudez, Daniel Curtis, Christopher J Wilson, Mustafa Q Hameed, Angelica D'Amore, Alexander Rotenberg, Mustafa Sahi. Seizure reduction in TSC2-mutant mouse model by an mTOR catalytic inhibitor. Annals of clinical and translational neurology. 2023-08-07. PMID:37545094. |
tuberous sclerosis complex (tsc) is a neurodevelopmental disorder caused by autosomal-dominant pathogenic variants in either the tsc1 or tsc2 gene, and it is characterized by hamartomas in multiple organs, such as skin, kidney, lung, and brain. |
2023-08-07 |
2023-08-14 |
mouse |
| Marjan Taherian, Paria Bayati, Mohammad-Ali Assarehzadegan, Mansoureh Soleimani, Hadi Poormoghim, Nazanin Mojtabav. Insights into Overlappings of Fibrosis and Cancer: Exploring the Tumor-related Cardinal Genes in Idiopathic Pulmonary Fibrosis. Iranian journal of allergy, asthma, and immunology. vol 22. issue 2. 2023-07-27. PMID:37496412. |
gene expression analyses indicated a significant elevation of regulatory associated protein of mtor (raptor), ras homolog enriched in brain (rheb), s6 kinase 1, and eukaryotic translation initiation factor 4e-binding protein 1 (4ebp1), as well as a significant reduction of vegfa, tuberous sclerosis complex (tsc2), and lrp1; no changes were observed in the tsc1 mrna level. |
2023-07-27 |
2023-08-14 |
mouse |
| Erin Gibbons, Briaunna M N Minor, Stephen R Hamme. Lymphangioleiomyomatosis: where endocrinology, immunology and tumor biology meet. Endocrine-related cancer. 2023-07-06. PMID:37410387. |
lymphangioleiomyomatosis (lam) is a cystic lung disease found almost exclusively in genetic females and caused by small clusters of smooth muscle cell tumors containing mutations in one of the two tuberous sclerosis genes (tsc1 or tsc2). |
2023-07-06 |
2023-08-14 |
Not clear |
| Xiaoling Xie, Wuju Zhang, Min Xiao, Tiantian Wei, Yingqi Qiu, Jingyang Qiu, Hao Wang, Zeyou Qiu, Sheng Zhang, Yating Pan, Linlin Mao, Yuhua Li, Bin Guo, Wanwen Yang, Yuxing Hu, Shujie Hu, Yan Gong, Jun Yang, Guozhi Xiao, Yue Zhang, Xiaochun Ba. TREM2 acts as a receptor for IL-34 to suppress acute myeloid leukemia in mice. Blood. vol 141. issue 26. 2023-07-05. PMID:37001042. |
here, we found that the development of aml xenotransplants was suppressed in mice with osteoclasts tuberous sclerosis 1 (tsc1) deletion. |
2023-07-05 |
2023-11-20 |
mouse |
| Pooja Navale, Deyali Chatterjee, Malak Itani, Nikolaos A Trikalino. Tuberous sclerosis complex mutations in patients with pancreatic neuroendocrine tumors. Observations on phenotypic and treatment-related associations. Virchows Archiv : an international journal of pathology. 2023-06-24. PMID:37354253. |
pancreatic neuroendocrine tumors (pannets) in familial tuberous sclerosis (tsc1 and tsc2 mutations) have been known and studied. |
2023-06-24 |
2023-08-14 |
Not clear |
| Rebecca A Reynolds, Diane J Aum, Ignacio Gonzalez-Gomez, Michael Wong, Kaleigh Roberts, Sonika Dahiya, Luis F Rodriguez, Jarod L Roland, Matthew D Smyt. Subependymal giant-cell astrocytomas in the absence of tuberous sclerosis. Journal of neurosurgery. Pediatrics. 2023-06-17. PMID:37327147. |
tuberous sclerosis is a rare genetic condition caused by tsc1 or tsc2 mutations that can be inherited, sporadic, or the result of somatic mosaicism. |
2023-06-17 |
2023-08-14 |
Not clear |
| Kleanthi Chalkiadaki, Elpida Statoulla, Maria Zafeiri, Nabila Haji, Jean-Claude Lacaille, Craig M Powell, Seyed Mehdi Jafarnejad, Arkady Khoutorsky, Christos G Gkogka. Reversal of memory and autism-related phenotypes in Frontiers in cell and developmental biology. vol 11. 2023-06-09. PMID:37293130. |
reversal of memory and autism-related phenotypes in tuberous sclerosis complex (tsc) is a rare monogenic disorder co-diagnosed with high rates of autism and is caused by loss of function mutations in the tsc1 or tsc2 genes. |
2023-06-09 |
2023-08-14 |
mouse |
| Hiroki Ura, Sumihito Togi, Mamoru Ozaki, Hisayo Hatanaka, Yo Niid. Establishment of human induced pluripotent stem cell lines, KMUGMCi006, from a patient with Tuberous sclerosis complex (TSC) bearing mosaic nonsense mutations in the Tuberous sclerosis complex 2 (TSC2) gene. Stem cell research. vol 70. 2023-06-04. PMID:37271041. |
tuberous sclerosis complex (tsc) is an autosomal dominant disorder characterized by neuropsychiatric symptoms and multiple dysplastic organ lesions, caused by loss of function mutations in either tsc1 or tsc2. |
2023-06-04 |
2023-08-14 |
human |
| Elisabetta Chiaradia, Ingrid Miller, Giovanni Renzone, Alessia Tognoloni, Alice Polchi, Federico De Marco, Brunella Tancini, Andrea Scaloni, Alessandro Magin. Proteomic analysis of murine Tsc1-deficient neural stem progenitor cells. Journal of proteomics. 2023-05-19. PMID:37207814. |
significance: tuberous sclerosis complex (tsc) is a multisystemic disorder caused by inactivating mutations of tsc1 or tsc2 genes, which induce overactivation of the mtor component. |
2023-05-19 |
2023-08-14 |
Not clear |
| Katarzyna Klonowska, Krinio Giannikou, Joannes M Grevelink, Barbara Boeszoermenyi, Aaron R Thorner, Zachary T Herbert, Antara Afrin, Alison M Treichel, Lana Hamieh, Katarzyna Kotulska, Sergiusz Jozwiak, Joel Moss, Thomas N Darling, David J Kwiatkowsk. Comprehensive genetic and phenotype analysis of 95 individuals with mosaic tuberous sclerosis complex. American journal of human genetics. 2023-05-04. PMID:37141891. |
tuberous sclerosis complex (tsc) is a neurogenetic disorder due to loss-of-function tsc1 or tsc2 variants, characterized by tumors affecting multiple organs, including skin, brain, heart, lung, and kidney. |
2023-05-04 |
2023-08-14 |
Not clear |
| Fateme Tehrani, Nahideh Khosroshahi, Zarrin Keihani Doust, Soheila Dabiran, Mohammad Reza Zarkes. The Efficacy and Safety of Rapamycin in Children with Tuberous Sclerosis: A Cross-sectional Study. Iranian journal of child neurology. vol 17. issue 2. 2023-04-24. PMID:37091468. |
mutations in tsc1 or tsc2 genes have been proposed as the main causative factors responsible for developing tuberous sclerosis complex (tsc). |
2023-04-24 |
2023-08-14 |
Not clear |
| Bryan A Adriaanse, Sinead Brady, Minghui Wang, Daniel J Beard, Jonathan I Spencer, Jonathan Pansieri, Brad A Sutherland, Margaret M Esiri, Alastair M Buchan, Zameel Cader, Bin Zhang, Gabriele C DeLuc. Tuberous Sclerosis Complex-1 (TSC1) contributes to selective neuronal vulnerability in Alzheimer's Disease. Neuropathology and applied neurobiology. 2023-04-06. PMID:37020385. |
tuberous sclerosis complex-1 (tsc1) contributes to selective neuronal vulnerability in alzheimer's disease. |
2023-04-06 |
2023-08-14 |
Not clear |
| Bryan A Adriaanse, Sinead Brady, Minghui Wang, Daniel J Beard, Jonathan I Spencer, Jonathan Pansieri, Brad A Sutherland, Margaret M Esiri, Alastair M Buchan, Zameel Cader, Bin Zhang, Gabriele C DeLuc. Tuberous Sclerosis Complex-1 (TSC1) contributes to selective neuronal vulnerability in Alzheimer's Disease. Neuropathology and applied neurobiology. 2023-04-06. PMID:37020385. |
we interrogated the expression of tuberous sclerosis complex-1 (tsc1; hamartin) and mtor-related proteins in hippocampal ca1 and ca3 subfields. |
2023-04-06 |
2023-08-14 |
Not clear |
| Xiaojuan Chao, Shaogui Wang, Xiaowen Ma, Chen Zhang, Hui Qian, Sha Neisha Williams, Zhaoli Sun, Zheyun Peng, Wanqing Liu, Feng Li, Namratha Sheshadri, Wei-Xing Zong, Hong-Min Ni, Wen-Xing Din. Persistent mTORC1 activation due to loss of liver tuberous sclerosis complex 1 promotes liver injury in alcoholic hepatitis. Hepatology (Baltimore, Md.). 2023-03-31. PMID:36999531. |
the aim of the study is to investigate the role and mechanisms of tuberous sclerosis complex 1 (tsc1) and mechanistic target of rapamycin complex 1 (mtorc1) in alcohol associated liver disease. |
2023-03-31 |
2023-08-14 |
Not clear |